What if the data collected during your pregnancy could predict and even prevent - a heart attack, a stroke, or dementia decades later? That's not a distant vision. That's exactly what HeraMed is building right now.

Anoushka Gungadin's path to CEO of HeraMed is anything but straight from growing up in Mauritius, to a decade in China, to building a leadership practice in Australia. And it's that exact breadth of experience that shapes the way she thinks about women's health. Because in her world, one size has never, and should never, fit all.

This is a conversation about technology, equity, and what it truly looks like to build healthcare that's designed around the woman not the other way around.

Key Takeaways:

• Find out how a girl from Mauritius who detoured through China and corporate boardrooms ...